Oppenheimer & Co. Inc. Appoints Andreas Argyrides As Executive Director and Senior Analyst Covering the Biotechnology Sector

Expanding the Depth and Breadth of Oppenheimer's Biotech Equity Research "We are thrilled to have Andreas join our biotech research team as we expand the depth and breadth of our industry expertise," said John Hellier, Senior Managing Director, Head of Equities for Oppenheimer. "He is well positioned to add value to Oppenheimer clients, given his wide and varied experiences across the healthcare industry." "Andreas is an ideal complement to Oppenheimer's Biotech research effort, and I look forward to workin ...